TCL Archive In Brief: Moffitt Center Makes Major Recruitment Effort; Komen Foundation Invites Award Nominations May 28, 1993
TCL Archive Recurrent Multiple Myeloma Responds To Revimid In Phase II, Side Effects Tolerable January 31, 2003